These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 30047430)

  • 21. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
    Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP
    J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developing a core set of outcome measure domains to study Raynaud's phenomenon and digital ulcers in systemic sclerosis: Report from OMERACT 2020.
    Maltez N; Hughes M; Brown E; Hickey V; Park H; Shea B; Herrick AL; Pauling JD; Proudman S; Merkel PA
    Semin Arthritis Rheum; 2021 Jun; 51(3):640-643. PubMed ID: 33947582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in the pathogenesis and management of Raynaud's phenomenon and digital ulcers.
    Herrick AL
    Curr Opin Rheumatol; 2016 Nov; 28(6):577-85. PubMed ID: 27541182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of biofeedback training in treatment of Raynaud's disease and phenomenon.
    Yocum DE; Hodes R; Sundstrom WR; Cleeland CS
    J Rheumatol; 1985 Feb; 12(1):90-3. PubMed ID: 3981523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical and capillaroscopic regression of CD30 anaplastic lymphoma associated with limited cutaneous systemic sclerosis following autologous bone marrow transplantation].
    Bellis R; Francès C; Barète S; Senet P
    Ann Dermatol Venereol; 2014; 141(6-7):446-51. PubMed ID: 24951144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database.
    Wirz EG; Jaeger VK; Allanore Y; Riemekasten G; Hachulla E; Distler O; Airò P; Carreira PE; Tikly M; Vettori S; Balbir Gurman A; Damjanov N; Müller-Ladner U; Distler J; Li M; Häusermann P; Walker UA;
    Ann Rheum Dis; 2016 Jul; 75(7):1285-92. PubMed ID: 26232495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Progressive systemic sclerosis].
    Schramm A; Maas D
    Med Klin; 1979 Nov; 74(46):1689-99. PubMed ID: 392285
    [No Abstract]   [Full Text] [Related]  

  • 28. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Narrow-sense' and 'broad-sense' vascular abnormalities of systemic sclerosis.
    Jinnin M
    Immunol Med; 2020 Sep; 43(3):107-114. PubMed ID: 32324110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Systemic sclerosis - a rare but important diagnosis in primary health care].
    Andreasson K; Lillpers K; Wollheim F; Hesselstrand R
    Lakartidningen; 2019 Sep; 116():. PubMed ID: 31573670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in Upper Extremity Scleroderma Wound Care.
    Cohen JM; Sibley RA; Chiu ES; Sharma S
    Adv Skin Wound Care; 2018 Oct; 31(10):446-455. PubMed ID: 30234574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of Raynaud's phenomenon and digital ischemic lesions in scleroderma.
    Hummers LK; Wigley FM
    Rheum Dis Clin North Am; 2003 May; 29(2):293-313. PubMed ID: 12841296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of Raynaud Phenomenon and Digital Ulcers in Scleroderma.
    Cappelli L; Wigley FM
    Rheum Dis Clin North Am; 2015 Aug; 41(3):419-38. PubMed ID: 26210127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of sclerodermal finger ulcers.
    Gahhos F; Ariyan S; Frazier WH; Cuono CB
    J Hand Surg Am; 1984 May; 9(3):320-7. PubMed ID: 6725888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral vasculopathy in patients with systemic sclerosis: difference in limited and diffuse subset of disease.
    Ostojić P; Damjanov N; Pavlov-Dolijanovic S; Radunović G
    Clin Hemorheol Microcirc; 2004; 31(4):281-5. PubMed ID: 15567898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible benefit of tadalafil cream for the treatment of Raynaud's phenomenon and digital ulcers in systemic sclerosis.
    Fernández-Codina A; Kazem M; Pope JE
    Clin Rheumatol; 2020 Mar; 39(3):963-965. PubMed ID: 32016657
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of systemic sclerosis.
    Pope JE
    Rheum Dis Clin North Am; 1996 Nov; 22(4):893-907. PubMed ID: 8923602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Raynaud phenomenon and digital ulcers in systemic sclerosis.
    Hughes M; Allanore Y; Chung L; Pauling JD; Denton CP; Matucci-Cerinic M
    Nat Rev Rheumatol; 2020 Apr; 16(4):208-221. PubMed ID: 32099191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.
    Minier T; Guiducci S; Bellando-Randone S; Bruni C; Lepri G; Czirják L; Distler O; Walker UA; Fransen J; Allanore Y; Denton C; Cutolo M; Tyndall A; Müller-Ladner U; Matucci-Cerinic M; ;
    Ann Rheum Dis; 2014 Dec; 73(12):2087-93. PubMed ID: 23940211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic sclerosis sine scleroderma and limited cutaneous systemic sclerosis: similarities and differences.
    Simeón-Aznar CP; Tolosa-Vilella C; Gabarró-Juliá L; Campillo-Grau M; Guillén Del Castillo A; Fonollosa-Plá V; Vilardell-Tarrés M
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-33-40. PubMed ID: 24776173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.